Progyny, Inc. (NASDAQ:PGNY – Get Rating) CEO Peter Anevski sold 16,000 shares of Progyny stock in a transaction on Monday, June 5th. The stock was sold at an average price of $40.00, for a total transaction of $640,000.00. Following the sale, the chief executive officer now directly owns 215,924 shares of the company’s stock, valued […]
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Director Kevin K. Gordon sold 1,410 shares of the company’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $38.24, for a total value of $53,918.40. Following the sale, the director now directly owns 12,354 shares of the company’s stock, valued […]
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Director Kevin K. Gordon sold 1,410 shares of the business’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $38.24, for a total transaction of $53,918.40. Following the completion of the transaction, the director now owns 12,354 shares of the company’s […]
Progyny, Inc. (NASDAQ:PGNY – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price objective among brokerages that have […]
Progyny, Inc. (NASDAQ:PGNY – Get Rating) CEO Peter Anevski sold 32,000 shares of the firm’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $36.30, for a total value of $1,161,600.00. Following the transaction, the chief executive officer now directly owns 215,924 shares in the company, valued […]